Aquestive Therapeutics (NASDAQ:AQST) just reported results for the fourth quarter of 2023.
- Aquestive Therapeutics reported earnings per share of -10 cents. This was below the analyst estimate for EPS of -8 cents.
- The company reported revenue of $13.21 million.
- This was 13.55% better than the analyst estimate for revenue of $11.63 million.